Search company, investor...

Predict your next investment

The Column Group company logo
Venture Capital
FINANCE | Asset/Financial Management
thecolumngroup.com

Investments

124

Portfolio Exits

23

Funds

7

About The Column Group

The Column Group is a venture capital firm dedicated to creating biotechnology companies.

Headquarters Location

1700 Owens Street Suite 500

San Francisco, California, 94158,

United States

415-865-2050

Want to inform investors similar to The Column Group about your company?

Submit your Analyst Briefing to get in front of investors, customers, and partners on CB Insights’ platform.

Expert Collections containing The Column Group

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Find The Column Group in 1 Expert Collection, including CB Insights Healthcare Smart Money Investors - 2020.

C

CB Insights Healthcare Smart Money Investors - 2020

25 items

Track the world's top-performing VC investors in healthcare. Firms are presented in alphabetical order.

Research containing The Column Group

Get data-driven expert analysis from the CB Insights Intelligence Unit.

CB Insights Intelligence Analysts have mentioned The Column Group in 2 CB Insights research briefs, most recently on Feb 16, 2021.

Latest The Column Group News

The Column Group snags big commitment from Orange County

Sep 1, 2023

Orange County Employees Retirement System committed $50m to TCG Crossover Fund II, joining the New Mexico State Investment Council and Rhode Island State Treasury. Register now to read this article and more for free. Email address I accept: Email address A link has been emailed to you - check your inbox. Sign in to your account Email address Nearly there! We have just sent you an email so you can verify your account. Please check your spam or junk folder just in case it’s been delivered there. If you do not receive this within five minutes, please try and sign in again. If the problem persists, please email: subscriptions@peimedia.com . Copyright PEI Media Share with other subscribers Cancel

The Column Group Investments

124 Investments

The Column Group has made 124 investments. Their latest investment was in Carmot Therapeutics as part of their Series E on May 5, 2023.

CBI Logo

The Column Group Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

5/25/2023

Series E

Carmot Therapeutics

$150M

No

9

2/13/2023

Series B

Hexagon Bio

$77.3M

No

2

1/6/2023

Series C

Synthekine

$100M

No

The Column Group, and Undisclosed Investors

7

12/22/2022

Series C - II

Subscribe to see more

$99M

Subscribe to see more

10

11/29/2022

Series A

Subscribe to see more

$99M

Subscribe to see more

10

Date

5/25/2023

2/13/2023

1/6/2023

12/22/2022

11/29/2022

Round

Series E

Series B

Series C

Series C - II

Series A

Company

Carmot Therapeutics

Hexagon Bio

Synthekine

Subscribe to see more

Subscribe to see more

Amount

$150M

$77.3M

$100M

$99M

$99M

New?

No

No

No

Subscribe to see more

Subscribe to see more

Co-Investors

The Column Group, and Undisclosed Investors

Sources

9

2

7

10

10

The Column Group Portfolio Exits

23 Portfolio Exits

The Column Group has 23 portfolio exits. Their latest portfolio exit was Sagimet Biosciences on July 18, 2023.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

7/18/2023

IPO

$99M

Public

4

10/29/2021

IPO

$99M

Public

7

7/30/2021

IPO

$99M

Public

4

5/27/2021

Acq - Pending

Subscribe to see more

$99M

Subscribe to see more

10

4/15/2021

Acq - Pending

Subscribe to see more

$99M

Subscribe to see more

10

Date

7/18/2023

10/29/2021

7/30/2021

5/27/2021

4/15/2021

Exit

IPO

IPO

IPO

Acq - Pending

Acq - Pending

Companies

Subscribe to see more

Subscribe to see more

Valuation

$99M

$99M

$99M

$99M

$99M

Acquirer

Public

Public

Public

Subscribe to see more

Subscribe to see more

Sources

4

7

4

10

10

The Column Group Fund History

7 Fund Histories

The Column Group has 7 funds, including PONOI CAPITAL.

Closing Date

Fund

Fund Type

Status

Amount

Sources

12/31/2017

PONOI CAPITAL

Early-Stage Venture Capital

Closed

1

4/27/2016

Column Group III

Subscribe to see more

Subscribe to see more

$99M

10

4/27/2016

Column Group III-A

$99M

10

9/16/2014

Column Group II

Subscribe to see more

Subscribe to see more

$99M

10

4/30/2008

Column Group LP

Subscribe to see more

Subscribe to see more

$99M

10

Closing Date

12/31/2017

4/27/2016

4/27/2016

9/16/2014

4/30/2008

Fund

PONOI CAPITAL

Column Group III

Column Group III-A

Column Group II

Column Group LP

Fund Type

Early-Stage Venture Capital

Subscribe to see more

Subscribe to see more

Subscribe to see more

Status

Closed

Subscribe to see more

Subscribe to see more

Subscribe to see more

Amount

$99M

$99M

$99M

$99M

Sources

1

10

10

10

10

The Column Group Team

8 Team Members

The Column Group has 8 team members, including current Founder, Managing Partner, Peter H. Svennilson.

Name

Work History

Title

Status

Peter H. Svennilson

Three Crowns Capital, and Nomura Holdings

Founder, Managing Partner

Current

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Name

Peter H. Svennilson

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Work History

Three Crowns Capital, and Nomura Holdings

Title

Founder, Managing Partner

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Status

Current

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Join a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.